共 83 条
[1]
Chobanian AV(2003)The Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report JAMA 289 2560-72
[2]
Bakris GL(2003)Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials Lancet 362 1527-35
[3]
Black HR(2004)Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial Lancet 364 849-57
[4]
Cushman WC(2005)Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study J Hypertens 23 445-53
[5]
Green LA(2000)Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: intervention as a goal in hypertension treatment (INSIGHT) Lancet 356 366-72
[6]
Izzo JL(2006)Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study Hypertens Res 29 789-96
[7]
Turnbull F(2005)Nifedipine gastrointestinal therapeutic system—hypertension management to improve cardiovascular outcomes Int J Clin Pract 59 1112-9
[8]
Poole-Wilson PA(2007)Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) J Hypertens 2007 1105-87
[9]
Lubsen J(1983)Nifedipine in the treatment of hypertension Eur J Clin Pharmacol 25 713-5
[10]
Kirwan BA(2010)Combination therapy in hypertension J Am Soc Hypertens 4 90-8